{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:08Z","timestamp":1787003648499,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96774-1","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T15:08:27Z","timestamp":1743865707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic significance of clinicopathological and ultrasonographic features in anaplastic thyroid carcinoma beyond TERT promoter mutation"],"prefix":"10.1038","volume":"15","author":[{"given":"Haejung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goeun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Lyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yeon","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"96774_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1245\/aso.2006.05.042","volume":"13","author":"C Are","year":"2006","unstructured":"Are, C. & Shaha, A. R. Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches. Ann. Surg. Oncol. 13, 453\u2013464. https:\/\/doi.org\/10.1245\/aso.2006.05.042 (2006).","journal-title":"Ann. Surg. Oncol."},{"key":"96774_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrendo.2017.76","volume":"13","author":"E Molinaro","year":"2017","unstructured":"Molinaro, E. et al. Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies. Nat. Rev. Endocrinol. 13, 644\u2013660. https:\/\/doi.org\/10.1038\/nrendo.2017.76 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"96774_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","volume":"6","author":"A Maniakas","year":"2020","unstructured":"Maniakas, A. et al. Evaluation of overall survival in patients with anaplastic thyroid Carcinoma, 2000\u20132019. JAMA Oncol. 6, 1397\u20131404. https:\/\/doi.org\/10.1001\/jamaoncol.2020.3362 (2020).","journal-title":"JAMA Oncol."},{"key":"96774_CR4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.20936","volume":"103","author":"E Kebebew","year":"2005","unstructured":"Kebebew, E., Greenspan, F. S., Clark, O. H., Woeber, K. A. & McMillan, A. Anaplastic thyroid carcinoma. Cancer 103, 1330\u20131335. https:\/\/doi.org\/10.1002\/cncr.20936 (2005).","journal-title":"Cancer"},{"key":"96774_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1089\/thy.2012.0302","volume":"22","author":"RC Smallridge","year":"2012","unstructured":"Smallridge, R. C. et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 22, 1104\u20131139. https:\/\/doi.org\/10.1089\/thy.2012.0302 (2012).","journal-title":"Thyroid"},{"key":"96774_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/hed.20578","volume":"29","author":"TY Kim","year":"2007","unstructured":"Kim, T. Y. et al. Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck 29, 765\u2013772. https:\/\/doi.org\/10.1002\/hed.20578 (2007).","journal-title":"Head Neck"},{"key":"96774_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1089\/thy.2020.0086","volume":"30","author":"B Xu","year":"2020","unstructured":"Xu, B. et al. Dissecting anaplastic thyroid Carcinoma: A comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases. Thyroid 30, 1505\u20131517. https:\/\/doi.org\/10.1089\/thy.2020.0086 (2020).","journal-title":"Thyroid"},{"key":"96774_CR8","doi-asserted-by":"publisher","first-page":"E632","DOI":"10.1210\/jc.2014-3606","volume":"100","author":"X Shi","year":"2015","unstructured":"Shi, X. et al. Association of TERT promoter mutation 1,295,228 C> T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer. J. Clin. Endocrinol. Metab. 100, E632\u2013E637 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96774_CR9","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/s0140-6736(13)60109-9","volume":"381","author":"M Xing","year":"2013","unstructured":"Xing, M., Haugen, B. R. & Schlumberger, M. Progress in molecular-based management of differentiated thyroid cancer. Lancet 381, 1058\u20131069. https:\/\/doi.org\/10.1016\/s0140-6736(13)60109-9 (2013).","journal-title":"Lancet"},{"key":"96774_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1677\/erc-08-0154","volume":"16","author":"RC Smallridge","year":"2009","unstructured":"Smallridge, R. C., Marlow, L. A. & Copland, J. A. Anaplastic thyroid cancer: Molecular pathogenesis and emerging therapies. Endocr. Relat. Cancer 16, 17\u201344. https:\/\/doi.org\/10.1677\/erc-08-0154 (2009).","journal-title":"Endocr. Relat. Cancer"},{"key":"96774_CR11","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1210\/jc.2012-2104","volume":"97","author":"C Li","year":"2012","unstructured":"Li, C., Lee, K. C., Schneider, E. B. & Zeiger, M. A. BRAFV600E mutation and its association with clinicopathological features of papillary thyroid cancer: A meta-analysis. J. Clin. Endocrinol. Metab. 97, 4559\u20134570. https:\/\/doi.org\/10.1210\/jc.2012-2104 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96774_CR12","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jama.2013.3190","volume":"309","author":"M Xing","year":"2013","unstructured":"Xing, M. et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309, 1493\u20131501. https:\/\/doi.org\/10.1001\/jama.2013.3190 (2013).","journal-title":"JAMA"},{"key":"96774_CR13","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1210\/jc.2012-1775","volume":"97","author":"R Elisei","year":"2012","unstructured":"Elisei, R. et al. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: Single-institution results from a large cohort study. J. Clin. Endocrinol. Metab. 97, 4390\u20134398. https:\/\/doi.org\/10.1210\/jc.2012-1775 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96774_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1089\/thy.2013.0675","volume":"24","author":"M Russo","year":"2014","unstructured":"Russo, M. et al. The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. Thyroid 24, 1267\u20131274. https:\/\/doi.org\/10.1089\/thy.2013.0675 (2014).","journal-title":"Thyroid"},{"key":"96774_CR15","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1001\/jamaoto.2013.4501","volume":"139","author":"C Gouveia","year":"2013","unstructured":"Gouveia, C. et al. Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience. JAMA Otolaryngol. Head Neck Surg. 139, 1164\u20131170. https:\/\/doi.org\/10.1001\/jamaoto.2013.4501 (2013).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"96774_CR16","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1245\/s10434-024-14935-4","volume":"31","author":"H-F Lai","year":"2024","unstructured":"Lai, H.-F. et al. BRAF V600E mutation lacks association with poorer clinical prognosis in papillary thyroid carcinoma. Ann. Surg. Oncol. 31, 3495\u20133501. https:\/\/doi.org\/10.1245\/s10434-024-14935-4 (2024).","journal-title":"Ann. Surg. Oncol."},{"key":"96774_CR17","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/erc-15-0533","volume":"23","author":"R Liu","year":"2016","unstructured":"Liu, R. & Xing, M. TERT promoter mutations in thyroid cancer. Endocr. Relat. Cancer 23, R143\u2013R155. https:\/\/doi.org\/10.1530\/erc-15-0533 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"96774_CR18","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1038\/onc.2013.446","volume":"33","author":"T Liu","year":"2014","unstructured":"Liu, T. et al. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene 33, 4978\u20134984. https:\/\/doi.org\/10.1038\/onc.2013.446 (2014).","journal-title":"Oncogene"},{"key":"96774_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1530\/erc-16-0219","volume":"23","author":"TH Kim","year":"2016","unstructured":"Kim, T. H. et al. TERT promoter mutations and long-term survival in patients with thyroid cancer. Endocr. Relat. Cancer 23, 813\u2013823. https:\/\/doi.org\/10.1530\/erc-16-0219 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"96774_CR20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1089\/thy.2015.0488","volume":"26","author":"SE Lee","year":"2016","unstructured":"Lee, S. E. et al. Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAF(V600E) mutation-prevalent population. Thyroid 26, 901\u2013910. https:\/\/doi.org\/10.1089\/thy.2015.0488 (2016).","journal-title":"Thyroid"},{"key":"96774_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/EJE-14-0837","volume":"172","author":"G Gandolfi","year":"2015","unstructured":"Gandolfi, G. et al. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Eur. J. Endocrinol. 172, 403\u2013413 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"96774_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41379-021-00907-6","volume":"35","author":"H Park","year":"2022","unstructured":"Park, H. et al. Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations. Mod. Pathol. 35, 186\u2013192 (2022).","journal-title":"Mod. Pathol."},{"key":"96774_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.mce.2014.10.019","volume":"399","author":"M Muzza","year":"2015","unstructured":"Muzza, M. et al. Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization. Mol. Cell. Endocrinol. 399, 288\u2013295 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"key":"96774_CR24","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2013-3734","volume":"99","author":"M Melo","year":"2014","unstructured":"Melo, M. et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J. Clin. Endocrinol. Metab. 99, E754\u2013E765. https:\/\/doi.org\/10.1210\/jc.2013-3734 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96774_CR25","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/jco.2014.55.5094","volume":"32","author":"M Xing","year":"2014","unstructured":"Xing, M. et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J. Clin. Oncol. 32, 2718\u20132726. https:\/\/doi.org\/10.1200\/jco.2014.55.5094 (2014).","journal-title":"J. Clin. Oncol."},{"key":"96774_CR26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/his.13942","volume":"75","author":"H Duan","year":"2019","unstructured":"Duan, H. et al. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing. Histopathology 75, 890\u2013899. https:\/\/doi.org\/10.1111\/his.13942 (2019).","journal-title":"Histopathology"},{"key":"96774_CR27","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/jci85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa, I. et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Invest. 126, 1052\u20131066. https:\/\/doi.org\/10.1172\/jci85271 (2016).","journal-title":"J. Clin. Invest."},{"key":"96774_CR28","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3390\/cancers12071973","volume":"12","author":"WA Lai","year":"2020","unstructured":"Lai, W. A., Liu, C. Y., Lin, S. Y., Chen, C. C. & Hang, J. F. Characterization of driver mutations in anaplastic thyroid carcinoma identifies RAS and PIK3CA mutations as negative survival predictors. Cancers 12, 1973. https:\/\/doi.org\/10.3390\/cancers12071973 (2020).","journal-title":"Cancers"},{"key":"96774_CR29","doi-asserted-by":"publisher","DOI":"10.1200\/po.21.00504","volume":"6","author":"JR Wang","year":"2022","unstructured":"Wang, J. R. et al. Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma. JCO Precis Oncol. 6, e2100504. https:\/\/doi.org\/10.1200\/po.21.00504 (2022).","journal-title":"JCO Precis Oncol."},{"key":"96774_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/thy.2013.0351","volume":"24","author":"SJ Rhee","year":"2014","unstructured":"Rhee, S. J. et al. Follicular variant of papillary thyroid carcinoma: distinct biologic behavior based on ultrasonographic features. Thyroid 24, 683\u2013688. https:\/\/doi.org\/10.1089\/thy.2013.0351 (2014).","journal-title":"Thyroid"},{"key":"96774_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3348\/kjr.2023.0461","volume":"25","author":"MK Kim","year":"2024","unstructured":"Kim, M. K. et al. Association of ultrasonography features of follicular thyroid carcinoma with tumor invasiveness and prognosis based on WHO classification and TERT promoter mutation. Korean J. Radiol. 25, 103\u2013112. https:\/\/doi.org\/10.3348\/kjr.2023.0461 (2024).","journal-title":"Korean J. Radiol."},{"key":"96774_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1148\/radiol.2015142470","volume":"277","author":"SY Kim","year":"2015","unstructured":"Kim, S. Y., Kwak, J. Y., Kim, E. K., Yoon, J. H. & Moon, H. J. Association of preoperative US features and recurrence in patients with classic papillary thyroid carcinoma. Radiology 277, 574\u2013583. https:\/\/doi.org\/10.1148\/radiol.2015142470 (2015).","journal-title":"Radiology"},{"key":"96774_CR33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1210\/jc.2012-4072","volume":"98","author":"SY Nam","year":"2013","unstructured":"Nam, S. Y. et al. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. J. Clin. Endocrinol. Metab. 98, 1476\u20131482. https:\/\/doi.org\/10.1210\/jc.2012-4072 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96774_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12020-017-1340-3","volume":"57","author":"TH Kim","year":"2017","unstructured":"Kim, T. H. et al. Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer. Endocrine 57, 234\u2013240. https:\/\/doi.org\/10.1007\/s12020-017-1340-3 (2017).","journal-title":"Endocrine"},{"key":"96774_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12020-020-02214-7","volume":"68","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter. Endocrine 68, 349\u2013357. https:\/\/doi.org\/10.1007\/s12020-020-02214-7 (2020).","journal-title":"Endocrine"},{"key":"96774_CR36","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1038\/s41598-023-30162-5","volume":"13","author":"S Cho","year":"2023","unstructured":"Cho, S. et al. Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma. Sci. Rep. 13, 3264 (2023).","journal-title":"Sci. Rep."},{"key":"96774_CR37","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3348\/kjr.2021.0713","volume":"22","author":"EJ Ha","year":"2021","unstructured":"Ha, E. J. et al. 2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean society of thyroid radiology consensus statement and recommendations. Korean J. Radiol. 22, 2094\u20132123. https:\/\/doi.org\/10.3348\/kjr.2021.0713 (2021).","journal-title":"Korean J. Radiol."},{"key":"96774_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jum.16034","volume":"42","author":"LP Haug","year":"2023","unstructured":"Haug, L. P., Dahiya, N., Young, S. W. & Patel, M. D. Thyroid nodule margin assessment using ACR TI-RADS: Adding points for macrolobulation impairs performance. J. Ultrasound. Med. 42, 409\u2013415. https:\/\/doi.org\/10.1002\/jum.16034 (2023).","journal-title":"J. Ultrasound. Med."},{"key":"96774_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","volume":"14","author":"FN Tessler","year":"2017","unstructured":"Tessler, F. N. et al. ACR thyroid imaging, reporting and data system (TI-RADS): White paper of the ACR TI-RADS committee. J. Am. Coll. Radiol. 14, 587\u2013595. https:\/\/doi.org\/10.1016\/j.jacr.2017.01.046 (2017).","journal-title":"J. Am. Coll. Radiol."},{"key":"96774_CR40","doi-asserted-by":"publisher","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","volume":"98","author":"I Landa","year":"2013","unstructured":"Landa, I. et al. Frequent somatic TERT promoter mutations in thyroid cancer: Higher prevalence in advanced forms of the disease. J. Clin. Endocrinol. Metab. 98, E1562-1566. https:\/\/doi.org\/10.1210\/jc.2013-2383 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96774_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/erc-13-0210","volume":"20","author":"X Liu","year":"2013","unstructured":"Liu, X. et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr. Relat. Cancer 20, 603\u2013610. https:\/\/doi.org\/10.1530\/erc-13-0210 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"96774_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/thy.2017.0526","volume":"28","author":"XV Nguyen","year":"2018","unstructured":"Nguyen, X. V., Roy Choudhury, K., Tessler, F. N. & Hoang, J. K. Effect of tumor size on risk of metastatic disease and survival for thyroid cancer: Implications for biopsy guidelines. Thyroid 28, 295\u2013300 (2018).","journal-title":"Thyroid"},{"key":"96774_CR43","doi-asserted-by":"publisher","DOI":"10.1200\/po.21.00504","author":"JR Wang","year":"2022","unstructured":"Wang, J. R. et al. Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/po.21.00504 (2022).","journal-title":"JCO Precis. Oncol."},{"key":"96774_CR44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1089\/thy.2016.0254","volume":"27","author":"B Bonhomme","year":"2017","unstructured":"Bonhomme, B. et al. Molecular pathology of anaplastic thyroid carcinomas: A retrospective study of 144 cases. Thyroid 27, 682\u2013692. https:\/\/doi.org\/10.1089\/thy.2016.0254 (2017).","journal-title":"Thyroid"},{"key":"96774_CR45","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1210\/jc.2011-3106","volume":"97","author":"A Guerra","year":"2012","unstructured":"Guerra, A. et al. A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. J. Clin. Endocrinol. Metab. 97, 2333\u20132340 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"96774_CR46","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.7863\/ultra.15.09058","volume":"35","author":"SY Hahn","year":"2016","unstructured":"Hahn, S. Y. & Shin, J. H. Description and comparison of the sonographic characteristics of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. J. Ultrasound Med. 35, 1873\u20131879. https:\/\/doi.org\/10.7863\/ultra.15.09058 (2016).","journal-title":"J. Ultrasound Med."},{"key":"96774_CR47","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.21037\/jtd.2017.09.48","volume":"9","author":"LS Gu","year":"2017","unstructured":"Gu, L. S. et al. Comparison of sonographic characteristics of primary thyroid lymphoma and anaplastic thyroid carcinoma. J. Thorac. Dis. 9, 4774\u20134784. https:\/\/doi.org\/10.21037\/jtd.2017.09.48 (2017).","journal-title":"J. Thorac. Dis."},{"key":"96774_CR48","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3349\/ymj.2013.54.6.1400","volume":"54","author":"HJ Suh","year":"2013","unstructured":"Suh, H. J., Moon, H. J., Kwak, J. Y., Choi, J. S. & Kim, E.-K. Anaplastic thyroid cancer: Ultrasonographic findings and the role of ultrasonography-guided fine needle aspiration biopsy. Yonsei Med. J. 54, 1400\u20131406 (2013).","journal-title":"Yonsei Med. J."},{"key":"96774_CR49","doi-asserted-by":"publisher","first-page":"W420","DOI":"10.2214\/ajr.09.3376","volume":"194","author":"SJ Yoon","year":"2010","unstructured":"Yoon, S. J. et al. \u201cTaller-than-wide sign\u201d of thyroid malignancy: Comparison between ultrasound and CT. AJR Am. J. Roentgenol. 194, W420-424. https:\/\/doi.org\/10.2214\/ajr.09.3376 (2010).","journal-title":"AJR Am. J. Roentgenol."},{"key":"96774_CR50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2214\/ajr.11.6446","volume":"198","author":"YL Seo","year":"2012","unstructured":"Seo, Y. L. et al. Compressibility of thyroid masses: A sonographic sign differentiating benign from malignant lesions?. AJR Am. J. Roentgenol. 198, 434\u2013438. https:\/\/doi.org\/10.2214\/ajr.11.6446 (2012).","journal-title":"AJR Am. J. Roentgenol."},{"key":"96774_CR51","unstructured":"Kettler, M. D. in Breast Imaging (eds Christoph I. Lee et al.) 0 (Oxford University Press, 2018)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96774-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96774-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96774-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T15:08:29Z","timestamp":1743865709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96774-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96774"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96774-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was approved by the Institutional Review Board of Samsung Medical Center (IRB No. SMC 2024-07-031), which waived the requirement for informed consent due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"11736"}}